Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy

Claudio Luchini^{1

2}, Liang Cheng^{3

4}

Affiliations

¹ Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
² Surgical Pathology Unit, Santa Chiara Hospital, Trento, Italy.
³ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
⁴ Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.

Editorial

Claudio Luchini et al. Transl Androl Urol. 2017 Oct.

. 2017 Oct;6(5):987-990.

doi: 10.21037/tau.2017.08.04.

Claudio Luchini^{1

2}, Liang Cheng^{3

4}

¹ Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
² Surgical Pathology Unit, Santa Chiara Hospital, Trento, Italy.
³ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
⁴ Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, Nawroth R, Schwamborn K, Tulic C, Simic T, Junker K, Harving N, Petersen AC, Jensen JB, Keck B, Grimm MO, Horstmann M, Maurer T, Steyerberg EW, Zwarthoff EC, Real FX, Malats N, Malmström PU, Ørntoft TF. Dyrskjøt L, et al. Eur Urol. 2017 Sep;72(3):461-469. doi: 10.1016/j.eururo.2017.05.040. Epub 2017 Jun 2. Eur Urol. 2017. PMID: 28583312

1. Moch H, Humphrey PA, Ulbright TM, et al. WHO classification of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2016. - PubMed
1. Babjuk M, Böhle A, Burger M, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. 10.1016/j.eururo.2016.05.041 - DOI - PubMed
1. Hong YM, Loughlin KR. Economic impact of tumor markers in bladder cancer surveillance. Urology 2008;71:131-5. 10.1016/j.urology.2007.08.014 - DOI - PubMed
1. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-5; discussion 475-7. - PubMed
1. van Rhijn BW, Zuiverloon TC, Vis AN, et al. Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer. Eur Urol 2010;58:433-41. 10.1016/j.eururo.2010.05.043 - DOI - PubMed